Our work supports previous studies that the suppression of PTEN plays a very significant role in drug resistance of NSCLC via activating the PI3K/Akt signaling pathway (Sun et al., 2019; Xiong et al., 2021). Here, AKT1 is linked to non-small cell lung carcinoma.